- Home
- ENSC vs BNBX Comparison
ENSC vs BNBX Comparison
Compare ENSC & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- BNBX
- Stock Information
- Founded
- ENSC 2003
- BNBX 1983
- Country
- ENSC United States
- BNBX United States
- Employees
- ENSC N/A
- BNBX N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- BNBX Other Consumer Services
- Sector
- ENSC Health Care
- BNBX Consumer Discretionary
- Exchange
- ENSC Nasdaq
- BNBX Nasdaq
- Market Cap
- ENSC 6.4M
- BNBX 5.5M
- IPO Year
- ENSC N/A
- BNBX N/A
- Fundamental
- Price
- ENSC $1.68
- BNBX $2.38
- Analyst Decision
- ENSC
- BNBX
- Analyst Count
- ENSC 0
- BNBX 0
- Target Price
- ENSC N/A
- BNBX N/A
- AVG Volume (30 Days)
- ENSC 79.2K
- BNBX 74.9K
- Earning Date
- ENSC 11-14-2025
- BNBX 12-16-2025
- Dividend Yield
- ENSC N/A
- BNBX N/A
- EPS Growth
- ENSC N/A
- BNBX N/A
- EPS
- ENSC N/A
- BNBX 211.51
- Revenue
- ENSC $4,487,973.00
- BNBX $3,743,063.00
- Revenue This Year
- ENSC N/A
- BNBX $57.08
- Revenue Next Year
- ENSC N/A
- BNBX $40.00
- P/E Ratio
- ENSC N/A
- BNBX $0.01
- Revenue Growth
- ENSC 1.51
- BNBX 55.60
- 52 Week Low
- ENSC $1.53
- BNBX $2.13
- 52 Week High
- ENSC $10.96
- BNBX $190.80
- Technical
- Relative Strength Index (RSI)
- ENSC 30.16
- BNBX N/A
- Support Level
- ENSC $1.53
- BNBX N/A
- Resistance Level
- ENSC $2.17
- BNBX N/A
- Average True Range (ATR)
- ENSC 0.14
- BNBX 0.00
- MACD
- ENSC -0.04
- BNBX 0.00
- Stochastic Oscillator
- ENSC 24.81
- BNBX 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About BNBX Applied DNA Sciences Inc. Common Stock
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.